Market Overview

Rite Aid To Sell Half Its Stores To Walgreens

Share:
Rite Aid To Sell Half Its Stores To Walgreens
Related RAD
New York City Bans Tobacco Sales In Pharmacies; Will Walgreens Follow CVS's Lead And Exit This Category?
TD Ameritrade Investor Movement Index: Bullish Retail Investors Push IMX Above 7.0 For First Time
Related WBA
Mylan Price Target Slashed Even As TLD Drug Receives Tentative Approval
Wall Street's M&A Chatter From August 2: Food Stocks, PharMerica, Hasbro-Lionsgate
John Buckingham Picks Up 4 Retailers in —nd Quarter (GuruFocus)

Shares of Rite Aid Corporation (NYSE: RAD) lost nearly 20 percent Thursday morning after the retail drugstore chain confirmed a finalized asset purchase agreement with rival Walgreens Boots Alliance Inc (NASDAQ: WBA).

Walgreens has attempted to acquire the entirety of Rite Aid since 2015, but instead Rite Aid will now sell 2,186 of its stores, related distribution assets and inventory for an all-cash purchase price of $5.175 billion. The stores are mostly located in the Northeast, Mid-Atlantic and Southeastern regions of the U.S..

The agreement gives Rite Aid the option to buy generic drugs that are sourced through an affiliate of Walgreens at cost for 10 years. In return, Rite Aid will provide certain transition services for up to three years after the transaction is expected to close within six months.

Since the transaction didn't end in a complete acquisition of Rite Aid, Walgreens will pay a termination fee of $325 million in cash.

The deal has already been approved by the board of directors of both companies and doesn't require a shareholder vote. The deal also remains subject to the appropriate regulatory and antitrust approvals.

"While we believe that pursuing the merger with WBA was the right thing to do for our investors and customers, this new agreement provides a clear path forward and positions Rite Aid as a strong, independent, multi-regional drugstore chain and pharmacy benefits manager with a compelling footprint in key markets," said Rite Aid Chairman and CEO John Standley. "The transaction offers clear solutions to assist us in addressing our pharmacy margin challenges and allows us to significantly reduce debt, resulting in a strong balance sheet and improved financial flexibility moving forward."

Related Links:

10 Stocks To Watch For June 29, 2017

Bank Of America: What To Expect For Rite Aid Ahead Of FTC Merger Decision

Image: Mike Mozart, Flickr

Posted-In: John Standley pharmacy Pharmacy Stocks retailers Walgreens Rite Aid MergerNews Asset Sales M&A Best of Benzinga

 

Related Articles (RAD + WBA)

View Comments and Join the Discussion!